BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2839149)

  • 1. Human placental calcitonin receptors.
    Nicholson GC; D'Santos CS; Evans T; Moseley JM; Kemp BE; Michelangeli VP; Martin TJ
    Biochem J; 1988 Mar; 250(3):877-82. PubMed ID: 2839149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization of functional calcitonin receptors.
    Nicholson GC; D'Santos CS; Evans T; Moseley JM; Kemp BE; Martin TJ
    Biochem J; 1988 Jul; 253(2):505-10. PubMed ID: 2845921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible calcitonin binding to solubilized sheep brain binding sites.
    Sexton PM; Schneider HG; D'Santos CS; Mendelsohn FA; Kemp BE; Moseley JM; Martin TJ; Findlay DM
    Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):179-84. PubMed ID: 1846527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
    D'Santos CS; Nicholson GC; Moseley JM; Evans T; Martin TJ; Kemp BE
    Endocrinology; 1988 Sep; 123(3):1483-8. PubMed ID: 2841096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin receptor in human placental syncytiotrophoblast brush border and basal plasma membranes.
    Lafond J; Simoneau L; Savard R; Lajeunesse D
    Mol Cell Endocrinol; 1994 Mar; 99(2):285-92. PubMed ID: 8206335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CGRP receptors in various regions of gerbil brain.
    Aiyar N; Baker E; Nambi P; Feuerstein G; Willette R
    Neuropeptides; 1994 May; 26(5):313-7. PubMed ID: 8065549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin receptors of human osteoclastoma.
    Nicholson GC; Horton MA; Sexton PM; D'Santos CS; Moseley JM; Kemp BE; Pringle JA; Martin TJ
    Horm Metab Res; 1987 Nov; 19(11):585-9. PubMed ID: 2828212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin receptors on circulating normal human lymphocytes.
    Body JJ; Glibert F; Nejai S; Fernandez G; Van Langendonck A; Borkowski A
    J Clin Endocrinol Metab; 1990 Sep; 71(3):675-81. PubMed ID: 2168433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between internalization and calcitonin-induced receptor loss in T 47D cells.
    Findlay DM; Martin TJ
    Endocrinology; 1984 Jul; 115(1):78-83. PubMed ID: 6329663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase.
    Marx SJ; Aurbach GD
    Endocrinology; 1975 Aug; 97(2):448-53. PubMed ID: 169126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs.
    Nakamuta H; Orlowski RC; Epand RM
    Endocrinology; 1990 Jul; 127(1):163-9. PubMed ID: 2163309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of angiotensin II binding sites in the human term placenta.
    Tencé M; Petit A
    Mol Cell Endocrinol; 1989 May; 63(1-2):111-9. PubMed ID: 2753221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors.
    Hilton JM; Dowton M; Houssami S; Sexton PM
    J Endocrinol; 2000 Jul; 166(1):213-26. PubMed ID: 10856900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous desensitization of calcitonin receptors and calcitonin-dependent adenylate cyclase in T47D cells.
    Schneider HG; Raue F; Koppold A; Ruf W; Ziegler R
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):373-8. PubMed ID: 8388616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction.
    Houssami S; Findlay DM; Brady CL; Myers DE; Martin TJ; Sexton PM
    Endocrinology; 1994 Jul; 135(1):183-90. PubMed ID: 8013352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor.
    Suva LJ; Flannery MS; Caulfield MP; Findlay DM; Jüppner H; Goldring SR; Rosenblatt M; Chorev M
    J Pharmacol Exp Ther; 1997 Nov; 283(2):876-84. PubMed ID: 9353409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells.
    Uzumaki H; Okabe T; Sasaki N; Hagiwara K; Takaku F; Tobita M; Yasukawa K; Ito S; Umezawa Y
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9323-6. PubMed ID: 2480598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.
    Perry KJ; Quiza M; Myers DE; Morfis M; Christopoulos G; Sexton PM
    Endocrinology; 1997 Aug; 138(8):3486-96. PubMed ID: 9231803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line.
    Hunt NH; Ellison M; Underwood JC; Martin TJ
    Br J Cancer; 1977 Jun; 35(6):777-84. PubMed ID: 194616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.